An Interim Report on a Phase 1/2 Study of HPN217, a Half-Life Extended Tri-Specific T Cell Activating Construct (TriTAC(r)) Targeting B Cell Maturation Antigen for the Treatment of Relapsed/Refractory Multiple Myeloma
HPN217
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: An Interim Report on a Phase 1/2 Study of HPN217, a Half-Life Extended Tri-Specific T Cell Activating Construct (TriTAC(r)) Targeting B Cell Maturation Antigen for the Treatment of Relapsed/Refractory Multiple Myeloma ### Output: HPN217